Ixekizumab for brodalumab-induced articular involvement in psoriatic arthritis: beyond IL-17A inhibition [0.03%]
伊克珠单抗治疗布罗利单抗诱导的银屑病关节炎关节受累：超越IL-17A抑制作用
Tomoyuki Mutoh,Masataka Kudo,Akira Tsukada
Tomoyuki Mutoh
Rheumatology hand signs in a Shepherd by Joachim Wtewael (1566-1638) [0.03%]
乔斯蒂安·沃特维尔(1566-1638)笔下的牧羊人与风湿病手征象
Hutan Ashrafian
Hutan Ashrafian
Prevalence and risk factors of depressive symptoms in children and adolescents with juvenile idiopathic arthritis [0.03%]
儿童及青少年特发性关节炎患者抑郁症状的患病率及其影响因素
Johanna Roemer,Ariane Klein,Gerd Horneff
Johanna Roemer
Depression is a serious disorder disproportionately affecting people with chronic diseases, yet, to date is rarely recognized comorbidity in pediatric rheumatology clinical routine care. The aim of this study was to investigate the prevalen...
Correlates of breakthrough Omicron (B.1.1.529) infections in a prospective cohort of vaccinated patients with rheumatic diseases [0.03%]
风湿病患者疫苗突破性感染Omicron(B.1.1.529)的危险因素：前瞻性队列研究
Libin Benny,Pankti Mehta,Sakir Ahmed et al.
Libin Benny et al.
Background: Data on the effectiveness of SARS-CoV-2 vaccines and the durability of protection against the prevalent Omicron variant are scarce, especially in patients with autoimmune rheumatic diseases (AIRDs). Hence, we ...
Oral or pulse glucocorticoid use at the onset of giant cell arteritis and its influence on the risk of relapse: a retrospective study [0.03%]
巨细胞动脉炎初发时口服或脉冲糖皮质激素的使用及其对复发风险的影响：一项回顾性研究
Laura Trives-Folguera,Juan Molina-Collada,Katerine López et al.
Laura Trives-Folguera et al.
The objective is to investigate whether initial therapy with intravenous methylprednisolone pulses (ivMTP) or oral glucocorticoid (OG) influences the relapse rate in giant cell arteritis (GCA) patients. This is a retrospective observational...
Observational Study
Rheumatology international. 2023 Jul;43(7):1333-1340. DOI:10.1007/s00296-023-05321-6 2023
New-onset giant cell arteritis with lower ESR and CRP level carries a similar ischemic risk to other forms of the disease but has an excellent late prognosis: a case-control study [0.03%]
新发巨细胞动脉炎患者血沉和C反应蛋白水平较低，但缺血风险与其他形式的该病类似且预后良好：一项病例对照研究
Eric Liozon,Simon Parreau,Stéphanie Dumonteil et al.
Eric Liozon et al.
Introduction: Biopsy-proven giant cell arteritis (GCA) occasionally presents without acute-phase reaction. In this setting, GCA may be initially overlooked and glucocorticoid treatment unduly delayed, potentially increasi...
Y Ross,S Jaleel,M Magrey
Y Ross
There have been significant advances in the treatment of psoriatic arthritis (PsA). Despite these advances, racial and ethnic disparities in clinical outcomes may still exist in patients with PsA. We aimed to examine the racial differences ...
Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results? [0.03%]
传统合成DMARDs的剂量会像生物制剂/靶向合成DMARD初治类风湿关节炎患者的QuantiFERON-TB金普利姆测试结果那样影响吗？
Zehra Ozsoy,Adem Ozdemir,Mustafa Ekici et al.
Zehra Ozsoy et al.
We aimed to obtain the effects of immunosuppressive doses on the QuantiFERON-TB Gold Plus (QFT-Plus) test results in Rheumatoid Arthritis (RA) patients. Besides this, the impact of the TB2 tube in QFT-Plus test was also investigated. This s...
Prevalence of rheumatoid arthritis in Greece: results from the national health examination survey EMENO [0.03%]
希腊类风湿性关节炎的患病率：国家健康检查调查EMENO的结果
Aliki I Venetsanopoulou,Natasa Kalpourtzi,Yannis Alamanos et al.
Aliki I Venetsanopoulou et al.
Rheumatoid arthritis (RA) is considered the most common form of autoimmune arthritis. The disease's prevalence is around 0.5-1% worldwide, but it seems to vary among different populations. The aim of this study was to estimate the prevalenc...
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey [0.03%]
系统性硬化病与COVID-19疫苗的安全性：来自全球自身免疫疾病中的新冠病毒疫苗安全性(COVAD)调查的短期见解
R Naveen,Darpan R Thakare,Masataka Kuwana et al.
R Naveen et al.
The safety profile of COVID-19 vaccines is understudied in patients with systemic sclerosis (SSc). We compared short-term adverse events (AEs) 7 days following vaccination in patients with SSc vs other rheumatic (AIRDs), non-rheumatic autoi...